Eli Lilly and Company's orforglipron had good results in Type 2 diabetes trials, potentially becoming the first scalable oral ...

--Off 4.72% from the Election Day close of 42221.88 on Tuesday, Nov. 5, 2024 --Off 7.50% from the Inauguration Day close of 43487.83 on Monday, Jan 20, 2025 --Off 4.73% since tariffs were announced on ...